Zurück zum FeedWebsite besuchen 
Lead-DossierGelandet18:43
CT-2026-301 Site Readiness | Clinical Trial Operations
mn1studio.online · Entdeckt vor 56 Min.
Warmer LeadSaaS
Zusammenfassung
Executive dashboard for Phase III trial CT-2026-301: site risk, activation readiness, regulatory status and enrollment across 24 US sites.
- Zielgruppe
- General
- Kategorie
- SaaS
- Land
- Unknown
- Status
- Live